Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-02-25 @ 9:47 PM
Study NCT ID:
NCT05249556
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-11-28
First Post:
2022-01-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old
Sponsor:
Immedica Pharma AB
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1042-CDD-3002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None